Literature DB >> 15082190

Reduced expression of brain-derived neurotrophic factor in mice deficient for pituitary adenylate cyclase activating polypeptide type-I-receptor.

Mathias Zink1, Christiane Otto, Björn Zörner, Christiane Zacher, Günther Schütz, Fritz A Henn, Peter Gass.   

Abstract

In vitro pituitary adenylate cyclase activating polypeptide (PACAP) induces the expression of brain-derived neurotrophic factor (BDNF) via its specific receptor PAC1. Since BDNF has been implicated in learning paradigms and mice lacking functional PAC1 have deficits in hippocampus-dependent associative learning, we investigated whether PAC1 mutants show alterations in hippocampal expression of BDNF and its receptor TrkB. Semi-quantitative in situ-hybridization using exon-specific BDNF-probes revealed significantly reduced expression of the exon-III and exon-V-specific transcripts within the hippocampal CA3 region in PAC1-deficient mice. A similar trend was observed for the exon-I-specific transcript. The expression of the exon-III-specific transcript was also reduced within the dentate gyrus, while Trk B-expression did not differ between genotypes. Our data demonstrate that even in vivo PAC1-mediated signaling seems to play a pivotal role for the transcriptional regulation of BDNF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15082190     DOI: 10.1016/j.neulet.2004.01.030

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Fear extinction and BDNF: translating animal models of PTSD to the clinic.

Authors:  R Andero; K J Ressler
Journal:  Genes Brain Behav       Date:  2012-05-11       Impact factor: 3.449

2.  Stimulation of synthesis and release of brain-derived neurotropic factor from intestinal smooth muscle cells by substance P and pituitary adenylate cyclase-activating peptide.

Authors:  M Al-Qudah; R Alkahtani; H I Akbarali; K S Murthy; J R Grider
Journal:  Neurogastroenterol Motil       Date:  2015-06-18       Impact factor: 3.598

3.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Enhances Hippocampal Synaptic Plasticity and Improves Memory Performance in Huntington's Disease.

Authors:  N Cabezas-Llobet; L Vidal-Sancho; M Masana; A Fournier; J Alberch; D Vaudry; X Xifró
Journal:  Mol Neurobiol       Date:  2018-03-10       Impact factor: 5.590

4.  The Effects of Prior Stress on Anxiety-Like Responding to Intra-BNST Pituitary Adenylate Cyclase Activating Polypeptide in Male and Female Rats.

Authors:  S Bradley King; Kim R Lezak; Micaela O'Reilly; Donna J Toufexis; William A Falls; Karen Braas; Victor May; Sayamwong E Hammack
Journal:  Neuropsychopharmacology       Date:  2017-01-20       Impact factor: 7.853

Review 5.  Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminalis (BNST) in mediating the behavioral consequences of chronic stress.

Authors:  Sayamwong E Hammack; Carolyn W Roman; Kimberly R Lezak; Margaret Kocho-Shellenberg; Bethany Grimmig; William A Falls; Karen Braas; Victor May
Journal:  J Mol Neurosci       Date:  2010-04-20       Impact factor: 3.444

6.  Adcyap1r1 genotype, posttraumatic stress disorder, and depression among women exposed to childhood maltreatment.

Authors:  Monica Uddin; Shun-Chiao Chang; Chao Zhang; Kerry Ressler; Kristina B Mercer; Sandro Galea; Katherine M Keyes; Katie A McLaughlin; Derek E Wildman; Allison E Aiello; Karestan C Koenen
Journal:  Depress Anxiety       Date:  2012-12-28       Impact factor: 6.505

Review 7.  Role of PACAP in ischemic neural death.

Authors:  Hirokazu Ohtaki; Tomoya Nakamachi; Kenji Dohi; Seiji Shioda
Journal:  J Mol Neurosci       Date:  2008-05-16       Impact factor: 3.444

Review 8.  Neurotransmitter, Peptide, and Steroid Hormone Abnormalities in PTSD: Biological Endophenotypes Relevant to Treatment.

Authors:  Ann M Rasmusson; Suzanne L Pineles
Journal:  Curr Psychiatry Rep       Date:  2018-07-17       Impact factor: 5.285

Review 9.  PACAP is implicated in the stress axes.

Authors:  Hitoshi Hashimoto; Norihito Shintani; Mamoru Tanida; Atsuko Hayata; Ryota Hashimoto; Akemichi Baba
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

10.  Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice.

Authors:  Dorothea Rat; Ulrich Schmitt; Frank Tippmann; Ilse Dewachter; Clara Theunis; Ewa Wieczerzak; Rolf Postina; Fred van Leuven; Falk Fahrenholz; Elzbieta Kojro
Journal:  FASEB J       Date:  2011-05-18       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.